SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (5951)1/26/1999 4:36:00 PM
From: sam  Respond to of 6136
 
Personally, I would have liked to see a larger premium -- from today's closing price. Principals must have feared that the deal leaked, and that's why the trading was halted. AGPH's price probably would have gotten above 60 if a rumor had been more widely dispersed. Now, with a slight time premium, and if arbs short WL (as many have been doing anyway), AGPH will be trading in this range for some time.



To: Biomaven who wrote (5951)1/26/1999 4:37:00 PM
From: Henry Niman  Respond to of 6136
 
WLA will acquire AGPH for about $60 in stock. Details linked to Merger Mania page at biocognizance.com



To: Biomaven who wrote (5951)1/26/1999 4:37:00 PM
From: Steve Fancy  Respond to of 6136
 
Peter, I think many shorts may have taken their misery the other day in that odd drop. Funny how somebody always seems to have some up from knowledge.

sf


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News